Home1KRYS • BIT
add
Krystal Biotech Inc
Previous close
€227.00
Year range
€110.10 - €263.40
Market cap
7.52B USD
Avg Volume
15.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 107.10M | 17.52% |
Operating expense | 56.24M | 25.50% |
Net income | 51.40M | 13.02% |
Net profit margin | 47.99 | -3.83% |
Earnings per share | 1.70 | 11.11% |
EBITDA | 44.83M | 7.67% |
Effective tax rate | -0.53% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 827.79M | 38.54% |
Total assets | 1.33B | 26.33% |
Total liabilities | 114.23M | 4.36% |
Total equity | 1.22B | — |
Shares outstanding | 29.23M | — |
Price to book | 5.43 | — |
Return on assets | 8.60% | — |
Return on capital | 9.31% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 51.40M | 13.02% |
Cash from operations | 77.51M | 46.68% |
Cash from investing | 11.16M | 113.32% |
Cash from financing | 15.67M | 545.22% |
Net change in cash | 103.70M | 456.35% |
Free cash flow | 49.43M | 55.80% |
About
Founded
2015
Headquarters
Website
Employees
295
